Рет қаралды 8
This session aims to explore the pivotal role of biobanks in Asia, Europe and the USA and how they are facilitating the seamless transition from cohort studies to clinical application.
03:30 Prof Aarno Palotie: FinnGen, an example of a Northern European large scale biobank study
23:30 Dr Geoffrey Ginsburg: The All of Us Research Program
51:30 Prof Masayuki Yamamoto: Challenge for Personalized Healthcare: the Tohoku Medical Megabank Project
1:14:45 Panel Discussion with Moderator Prof Nahla Afifi, International Health Cohorts Consortium (IHCC)